JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258463

Human IFI27 knockout A549 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

IFI27 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 146 bp deletion in exon4.

View Alternative Names

2310061N23Rik, FAM 14D, IFI27_HUMAN, ISG 12, ISG12(a), ISG12(a) protein, ISG12A, Interferon alpha-induced 11.5 kDa protein, Interferon alpha-inducible protein 27, Interferon inducible protein 27, Interferon-stimulated gene 12a protein, interferon alpha-inducible protein 27, mitochondrial, interferon-stimulated gene 12, mitochondrial, p27

1 Images
Sanger Sequencing - Human IFI27 knockout A549 cell lysate (AB258463)
  • Sanger seq

Unknown

Sanger Sequencing - Human IFI27 knockout A549 cell lysate (AB258463)

Homozygous : 146 bp deletion in exon4

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 146 bp deletion in exon4.

Disease

Carcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258463-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human IFI27 knockout A549 cell lysate", "number":"AB258463-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A549 cell lysate", "number":"AB258463-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
IFI27
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

IFI27 also known as Interferon alpha-inducible protein 27 is a small protein with a molecular mass of around 12 kilodaltons. This protein is expressed predominantly in response to type I interferons and some other stimuli. It mainly appears in tissues like the skin and liver which are involved in immune responses. IFI27 localizes to the mitochondria suggesting its role in regulating cellular apoptosis.
Biological function summary

IFI27 plays a significant role in mediating apoptosis the programmed cell death essential for normal cellular turnover and homeostasis. Although it does not typically form part of a larger protein complex its induction by interferons implicates it in antiviral defense mechanisms. Its expression can lead to changes in mitochondrial membrane potential ultimately affecting cell survival.

Pathways

IFI27 participates in important pathways related to immunity and apoptosis. Particularly it engages in the interferon signaling pathway influencing the cellular defense against viral infections. It interacts with other proteins like STAT1 and STAT2 which are key transcription factors in the interferon signaling cascade modulating downstream antiviral responses.

IFI27 has associations with chronic liver diseases and certain autoimmune conditions such as systemic lupus erythematosus (SLE). Its elevated expression often indicates an active immune response or cellular stress. IFI27's expression relates to IFI6 another interferon-inducible protein both of which are implicated in the cellular responses observed in these conditions. Understanding IFI27's role may help in developing therapeutic strategies for targeting immune-related disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com